ATE245155T1 - N-substituierte 1-(butyrolacton)-isochinoline zur behandlung von nervenstörungen - Google Patents
N-substituierte 1-(butyrolacton)-isochinoline zur behandlung von nervenstörungenInfo
- Publication number
- ATE245155T1 ATE245155T1 AT00969659T AT00969659T ATE245155T1 AT E245155 T1 ATE245155 T1 AT E245155T1 AT 00969659 T AT00969659 T AT 00969659T AT 00969659 T AT00969659 T AT 00969659T AT E245155 T1 ATE245155 T1 AT E245155T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- nervous disorders
- isochinolines
- butyrolactone
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9913232A FR2800072B1 (fr) | 1999-10-22 | 1999-10-22 | 1-(2-butyrolactones et 2-thiobutyrolactones)-isoquinolines n-substituees utiles comme stimulant de l'activite de l'acide gamma-aminobutyrique et dans le traitement des troubles nerveux et leur procede de preparation |
PCT/FR2000/002927 WO2001029030A1 (fr) | 1999-10-22 | 2000-10-20 | 1-(lactone)-isoquinolones n-substituees pour le traitement des troubles nerveux |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE245155T1 true ATE245155T1 (de) | 2003-08-15 |
Family
ID=9551261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00969659T ATE245155T1 (de) | 1999-10-22 | 2000-10-20 | N-substituierte 1-(butyrolacton)-isochinoline zur behandlung von nervenstörungen |
Country Status (9)
Country | Link |
---|---|
US (1) | US6649626B1 (de) |
EP (1) | EP1224182B1 (de) |
JP (1) | JP2003512373A (de) |
AT (1) | ATE245155T1 (de) |
AU (1) | AU7932000A (de) |
CA (1) | CA2387972A1 (de) |
DE (1) | DE60003941T2 (de) |
FR (1) | FR2800072B1 (de) |
WO (1) | WO2001029030A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005315937A1 (en) * | 2004-12-17 | 2006-06-22 | F. Hoffmann-La Roche Ag | Thieno-pyridine derivatives as GABA-B allosteric enhancers |
MX2007014929A (es) * | 2005-06-02 | 2008-02-15 | Hoffmann La Roche | 3-metansulfonilquinolinas como mejoradores de gaba-b. |
US8476297B2 (en) * | 2007-12-04 | 2013-07-02 | Amgen Inc. | TRP-M8 receptor ligands and their use in treatments |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8921304D0 (en) * | 1989-09-20 | 1989-11-08 | Wyeth John & Brother Ltd | New method of treatment and heterocyclic compounds used therein |
FR2750427B1 (fr) * | 1996-06-28 | 1998-08-07 | Synthelabo | Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique |
-
1999
- 1999-10-22 FR FR9913232A patent/FR2800072B1/fr not_active Expired - Fee Related
-
2000
- 2000-10-20 DE DE60003941T patent/DE60003941T2/de not_active Expired - Fee Related
- 2000-10-20 AT AT00969659T patent/ATE245155T1/de not_active IP Right Cessation
- 2000-10-20 AU AU79320/00A patent/AU7932000A/en not_active Abandoned
- 2000-10-20 JP JP2001531829A patent/JP2003512373A/ja active Pending
- 2000-10-20 US US10/111,081 patent/US6649626B1/en not_active Expired - Fee Related
- 2000-10-20 CA CA002387972A patent/CA2387972A1/fr not_active Abandoned
- 2000-10-20 WO PCT/FR2000/002927 patent/WO2001029030A1/fr active IP Right Grant
- 2000-10-20 EP EP00969659A patent/EP1224182B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2003512373A (ja) | 2003-04-02 |
FR2800072B1 (fr) | 2002-01-11 |
DE60003941T2 (de) | 2004-05-06 |
US6649626B1 (en) | 2003-11-18 |
EP1224182A1 (de) | 2002-07-24 |
FR2800072A1 (fr) | 2001-04-27 |
DE60003941D1 (de) | 2003-08-21 |
AU7932000A (en) | 2001-04-30 |
WO2001029030A1 (fr) | 2001-04-26 |
CA2387972A1 (fr) | 2001-04-26 |
EP1224182B1 (de) | 2003-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04007470A (es) | Piridinonas sustituidas. | |
TW200517109A (en) | Substituted pyridinones | |
DE60041973D1 (de) | Substituierte piperidin-verbindungen als modulatoren der chemokine receptor aktivität | |
EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
BG104663A (en) | N-acyl cyclic amine derivatives | |
TW200507839A (en) | Therapeutic agents | |
DE60132309D1 (de) | Amin-derivate zur behandlung von apoptosis | |
DE60005560D1 (de) | Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems | |
IL176546A0 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
FR2800735B1 (fr) | Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation | |
SE9903894D0 (sv) | Novel compounds | |
HRP20010969B1 (en) | Novel piperazinylalkylthiopyrimidine derivatives, | |
DE69837564D1 (de) | Azaheterozyklischederivate zur behandlung von haarausfall und neurologischer krankheiten | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
ATE245155T1 (de) | N-substituierte 1-(butyrolacton)-isochinoline zur behandlung von nervenstörungen | |
DE69518159D1 (de) | Mittel zur vorsorge und heilung von typ i allergischen krankheiten | |
ATE374366T1 (de) | Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen | |
ATE263760T1 (de) | 3-amino-2,2-di-c-alkyl-1,4-butyrolactone und n- substituierte 1,4-thiobutyrolactone die zur stimulation der gamma-aminobutansäureaktivität und zur behandlung von nervenerkrankungen verwendung finden, sowie verfahren zu ihrer herstellung | |
ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
ATE314339T1 (de) | Polyhydroxyphenolderivate und mittel zur vorbeugung und therapie von knochen- und knorpelkrankheiten die diese enthalten | |
RU2221786C2 (ru) | Производные тетрагидроизохинолиналканола, способы лечения и фармацевтические композиции на их основе | |
ATE64095T1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
ATE168697T1 (de) | Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen | |
SG153727A1 (en) | Substituted pyridinones as modulators of p38 map kinase | |
TH35496B (th) | วิธีการใช้คาร์บาแมตบำรุงประสาทและยูเรีย |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |